AB超短期收益主動型ETF YEAR 深 滬
已收盤 11-06 16:00:00 美东时间
50.145
-0.015
-0.03%
華盛通- 最 高50.1581
- 今 開50.12
- 成交量 10.62万股
- 最 低 50.12
- 昨 收 50.16
- 總市值 15.92亿
- 52周最高 50.16
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 48.5771
- 委 比 33.33%
- 總股本 3175.10万
- 歷史最高 50.1581
- 量 比 1.12
- 振 幅 0.08%
- 歷史最低 40.1771
- 每 手 1
- 風險率 0.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多LETTER TO SHAREHOLDERS
Devon Energy has achieved significant milestones since its Coterra combination, including a comprehensive portfolio review, strategic divestitures, and major acquisitions in the Permian Basin. The company emphasizes operational excellence, technology innovation, and a disciplined approach to capital allocation. Key initiatives include expanding in the Permian Basin, optimizing complementary assets, and enhancing shareholder returns through increa...
11-05 21:11
J & J SNACK FOODS SCHEDULES FOURTH QUARTER and FISCAL YEAR EARNINGS CONFERENCE CALL AND WEBCAST
J&J Snack Foods Corp. announced it will release its fourth-quarter and fiscal year 2026 financial results on November 18, 2026, before the market opens. A conference call and webcast to discuss the results will be held at 10:00 a.m. Eastern Time that day. Investors can pre-register via a provided link to receive the dial-in number and PIN. The live webcast will be accessible on the company’s investor relations website or through a direct link. J&...
10-30 11:00
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
argenx reported strong third-quarter 2026 results, with VYVGART driving $1.7 billion in global product net sales, up 54% year-over-year and 13% quarter-over-quarter. The company advanced multiple clinical programs, including submitting an sBLA for VYVGART Hytrulo in IMNM and progressing empasiprubart's Phase 3 MMN data expected in December 2026. argenx also advanced FB102 to Phase 3 in celiac disease. Financially, the company achieved operating i...
10-22 05:00
AAR Non-GAAP EPS of $1.49 beats by $0.20, revenue of $918M beats by $38.03M
AAR press release (AIR): Q1 Non-GAAP EPS of $1.49 beats by $0.20. Revenue of $918M (+24.1% Y/Y) beats by $38.03M. Share -0.88% SECOND QUARTER AND FULL YEAR FISCAL 2027 GUIDANCE The Company is providin...
09-29 04:55
Keytronic (KTCC) FY2026 Q4 Earnings Call: Revenue Rebounds as Liquidity Limits Shipments
Keytronic’s FY2026 Q4 revenue rose 14% sequentially to $102 million, while liquidity delayed $10 million of shipments. Management targets FY2027 growth and profitability.
08-28 00:00
XBP Global (XBP) 2026财年第二季度业绩电话会议：利润率创历史新高与更强劲的新增订单
XBP Global 2026财年第二季度财报电话会议强调了创纪录的调整后毛利率、2190万美元的标准化EBITDA，以及尽管营收下滑但依然更为强劲的新签订单额。
08-14 08:45
VirTra (VTSI) 2026财年第二季度业绩电话会：营收改善，在手订单达2490万美元
VirTra 2026财年第二季度业绩电话会议涵盖了580万美元的营收、550万美元的预订额、2490万美元的积压订单、利润率压力以及资金活动的改善。
08-14 08:44
泰农医疗 (TNON) 2026财年第二季度业绩电话会议：营收增长127%，利润率提升
得益于手术量增加和Symmetry Plus销售额增长，Tenon Medical 2026财年第二季度营收增长127%至130万美元，毛利率达到64%。
08-14 08:43
